160 related articles for article (PubMed ID: 2531424)
1. Pharmacological properties of YM-11124, a selective immunosuppressive agent for cell-mediated immunity.
Tomioka K; Yamada T; Mase T; Murase K
Pharmacology; 1989; 39(1):28-38. PubMed ID: 2531424
[TBL] [Abstract][Full Text] [Related]
2. [Effects of YM-13650 on type I to type IV allergic reactions and immune responses in animals].
Yamada T; Tomioka K; Mase T; Murase K
Nihon Yakurigaku Zasshi; 1991 Feb; 97(2):75-84. PubMed ID: 1829062
[TBL] [Abstract][Full Text] [Related]
3. Immunopharmacological actions of the new antiallergic drug butyl 3'-(1H-tetrazol-5-yl)oxanilate. 1st communication: effects on type I to type IV allergic reactions in animal models.
Yanagihara Y; Abe T; Edanami K; Agata M; Kuroda T; Shida T
Arzneimittelforschung; 1988 Jan; 38(1):70-4. PubMed ID: 2966629
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of epinastine on the type II-IV allergic reactions in mice, rats and guinea pigs.
Kamei C; Izushi K; Adachi Y; Shimazawa M; Tasaka K
Arzneimittelforschung; 1991 Nov; 41(11):1150-3. PubMed ID: 1687348
[TBL] [Abstract][Full Text] [Related]
5. [[Effect of traxanox sodium on type I-IV allergic reactions. Studies on anti-allergic agents VII].
Terasawa M; Goto K; Maruyama Y
Nihon Yakurigaku Zasshi; 1982 Dec; 80(6):417-27. PubMed ID: 6219052
[TBL] [Abstract][Full Text] [Related]
6. [Effects of ferulic acid on allergic reaction].
Hu HJ; Hang BQ
Zhongguo Yao Li Xue Bao; 1991 Sep; 12(5):426-30. PubMed ID: 1840284
[TBL] [Abstract][Full Text] [Related]
7. Immunopharmacological studies on TBX, a new antiallergic drug (4). Effects on type II to IV allergic reactions and immunological functions in animal models.
Yanagihara Y; Kasai H; Kawashima T; Ninomiya K
Jpn J Pharmacol; 1989 Sep; 51(1):93-100. PubMed ID: 2530379
[TBL] [Abstract][Full Text] [Related]
8. Effects of DS-4574, a new orally active antiallergic agent, in experimental allergic and inflammatory models.
Aibara S; Mori M; Iwamoto T; Tsubokawa M; Takamori H; Tsukada W
Jpn J Pharmacol; 1993 Apr; 61(4):267-76. PubMed ID: 8320873
[TBL] [Abstract][Full Text] [Related]
9. Acute effects of deflazacort and its metabolite 21-desacetyl-deflazacort on allergic reactions.
Omote M; Sakai K; Mizusawa H
Arzneimittelforschung; 1994 Feb; 44(2):149-53. PubMed ID: 7511903
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of a non-steroidal anti-inflammatory agent, an immunosuppressive, a corticosteroid and an immunomodulator on various immunological and non-immunological inflammatory experimental models.
Tarayre JP; Lauressergues H
Arch Int Pharmacodyn Ther; 1979 Nov; 242(1):159-76. PubMed ID: 161700
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacological studies on oxatomide (KW-4354): (2) Effect on the experimental models of the type 1-type 4 allergic reactions].
Ohmori K; Ishii H; Hirayama T; Shuto K; Nakamizo N
Nihon Yakurigaku Zasshi; 1982 Sep; 80(3):261-70. PubMed ID: 6130033
[TBL] [Abstract][Full Text] [Related]
12. [Effect of KC-404 on allergic reactions types I-IV].
Nishino K; Hara S; Irikura T
Nihon Yakurigaku Zasshi; 1984 Apr; 83(4):291-9. PubMed ID: 6235160
[TBL] [Abstract][Full Text] [Related]
13. [Effects of MY-5116 on experimental animal models of type I-type IV allergic reactions and the formation of IgE antibody].
Takahashi K; Endoh K; Yamada N; Kadowaki S; Arai Y; Sugasawa K
Nihon Yakurigaku Zasshi; 1986 Sep; 88(3):245-54. PubMed ID: 2947841
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological studies of N-(2-mercapto-2-methylpropanoyl)-L-cysteine (SA96) (3). Effects of SA96 on experimental allergic reactions.
Nakata K; Suda H; Yamauchi H; Iso T
Jpn J Pharmacol; 1985 Jan; 37(1):83-90. PubMed ID: 3157817
[TBL] [Abstract][Full Text] [Related]
15. Effects of FR50948, a new orally active antiallergic agent, in experimental allergic models.
Hiroi J; Ohara K; Kobayashi K; Fujitsu T; Fujii T; Motoyama Y; Mori J; Shibayama F
Jpn J Pharmacol; 1988 Apr; 46(4):337-48. PubMed ID: 2457128
[TBL] [Abstract][Full Text] [Related]
16. Anti-allergic effects of ketanserin on animal models of allergic reactions.
Nagai H; Suda H; Kitagaki K; Goto S; Miura T; Koda A
Arch Int Pharmacodyn Ther; 1990; 307():172-82. PubMed ID: 1710442
[TBL] [Abstract][Full Text] [Related]
17. [Effect of suplatast tosilate (IPD-1151T) on types I-IV allergic reactions].
Matsuura N; Mori H; Nagai H; Koda A
Nihon Yakurigaku Zasshi; 1992 Dec; 100(6):495-501. PubMed ID: 1282894
[TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory properties of zinc protoporphyrin disodium (Zn-PP-2Na).
Nagai H; Kitagaki K; Kuwabara K; Koda A
Agents Actions; 1992 Nov; 37(3-4):273-83. PubMed ID: 1295376
[TBL] [Abstract][Full Text] [Related]
19. [Anti-allergic effects of (E)-3-[p-(1H-imidazol-1-ylmethyl)phenyl]-2-propenoic acid (OKY-046), a specific thromboxane (TX) A2 synthetase inhibitor: effect of OKY-046 on II-IV type allergic reactions].
Kikuchi S; Takehana Y; Hamano S; Ichikawa K; Komatsu H; Okegawa T; Ikeda S
Nihon Yakurigaku Zasshi; 1990 Mar; 95(3):131-7. PubMed ID: 2141317
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of methanolic extract from corydalis tuber against types I-IV allergic models.
Matsuda H; Tokuoka K; Wu J; Tanaka T; Kubo M
Biol Pharm Bull; 1995 Jul; 18(7):963-7. PubMed ID: 7581251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
